Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Hepatology

• Publication date

  2017-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.29369PMID 28714089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.

  2017cited by this paper
• Rifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study

  2017cited by this paper
• Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

  2017cited by this paper
• Altered profile of human gut microbiome is associated with cirrhosis and its complications.

  2014influential reference
• In vitro Activity of Rifaximin, Metronidazole and Vancomycin against Clostridium difficile and the Rate of Selection of Spontaneously Resistant Mutants against Representative Anaerobic and Aerobic Bacteria, Including Ammonia-Producing Species

  2000cited by this paper

• Advances in understanding, diagnosing, and treating hepatic encephalopathy: from epidemiology to emerging therapies.

  2026cites this paper
• A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy

  2025cites this paper
• Efficacies of Bifidobacterium and Fecal Microbiota Transplantation in Rats With Chronic Hepatic Encephalopathy Assessed by [18F]PBR146 Imaging of Neuroinflammation

  2025cites this paper
• Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis

  2025cites this paper
• Comparison of the use of a spiral nasojejunal tube and transendoscopic enteral tubing in washed microbiota transplantation via the mid-gut route

  2024cites this paper
• Faecal microbiota transplantation associated adverse events

  2024cites this paper
• Microbiota-gut-liver-brain axis and hepatic encephalopathy

  2024cites this paper
• The Role of Gut Microbiome-Derived Short Chain Fatty Acid Butyrate in Hepatobiliary Diseases.

  2023cites this paper
• The role of gut microbiome and fecal microbiota transplantation in liver cancer and related complications: mechanisms and therapeutic potentials

  2023cites this paper
• Hepatic encephalopathy – recent advances in treatment and diagnosis

  2023influential citation
• The potential application of probiotics for the prevention and treatment of COVID-19

  2022cites this paper
• Gut microbiome dysbiosis in malnutrition.

  2022cites this paper
• Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation

  2022cites this paper
• Hepatic encephalopathy

  2022cites this paper
• Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy —current validation level and practical use

  2022cites this paper
• Gut microbiome in liver pathophysiology and cholestatic liver disease

  2021cites this paper
• [Fecal microbiota transplantation: donor selection criteria, storage and preparation of biomaterials (review of current recommendations)].

  2021cites this paper
• Modern approaches to the correction of the gut microbiota

  2021cites this paper
• Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome

  2021cites this paper
• Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives

  2021cites this paper
• Legal aspects of intestinal microbiome application.

  2021cites this paper
• Leveraging diet to engineer the gut microbiome

  2021cites this paper
• Gut and Cutaneous Microbiome Featuring Abundance of Lactobacillus reuteri Protected Against Psoriasis-Like Inflammation in Mice

  2021cites this paper
• Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease

  2020cites this paper
• Our Microbiome: On the Challenges, Promises, and Hype.

  2020influential citation
• Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.

  2020cites this paper
• Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis

  2020cites this paper
• Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers

  2020cites this paper
• The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives

  2020cites this paper
• Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease

  2020cites this paper
• Current and future targets for faecal microbiota transplantation

  2019cites this paper
• Microbiota transplantation: Targeting cancer treatment.

  2019cites this paper
• Microbiota modification in hematology: still at the bench or ready for the bedside?

  2019cites this paper
• Microbiota modification in hematology: still at the bench or ready for the bedside?

  2019cites this paper
• The recognition and attitudes of postgraduate medical students toward fecal microbiota transplantation: a questionnaire study

  2019cites this paper
• A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research

  2019cites this paper
• Microbial Profiles of Cirrhosis in the Human Small Intestine

  2019cites this paper
• The effect of fecal microbiota transplantation on Hepatic myelopathy

  2019cites this paper
• Fecal microbiota transplantation in children: current concepts.

  2019cites this paper
• Fecal Microbiota Transplants as a Treatment Option for Parkinson’s Disease

  2018cites this paper
• Fecal Microbial Transplant for Antibiotic‐Associated Disruption in Cirrhosis

  2018cites this paper
• Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy

  2018cites this paper
• Microbiota transplantation: concept, methodology and strategy for its modernization

  2018cites this paper